title: Schedules of Controlled Substances: Table of Excluded Nonnarcotic   Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
abstract: This final rule adopts, without change, the interim final rule that was published in the Federal Register on October 27, 2015. The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
mesh_terms: D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D008694:Methamphetamine / Q000145:classification*; D014663:Nasal Decongestants / Q000145:classification*; D009330:Nebulizers and Vaporizers / Q000145:classification*; D004366:Nonprescription Drugs / Q000145:classification; D014481:United States
chemical_list: D014663:Nasal Decongestants; D004366:Nonprescription Drugs; D008694:Methamphetamine